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Corneal Involvement in Rheumatoid Arthritis:
An In Vivo Confocal Study
Edoardo Villani,1 Daniela Galimberti,1 Francesco Viola,1 Chiara Mapelli,1
Nicoletta Del Papa,2 and Roberto Ratiglia1
PURPOSE. To analyze the in vivo morphology of corneal cells
and nerves in patients with rheumatoid arthritis (RA), with or
without secondary Sjo¨gren’s syndrome (SSII), and to investi-
gate the correlations between corneal alterations and RA activ-
ity.
METHODS. Fifty patients with RA and 30 age- and gender-
matched control subjects were studied. SSII was diagnosed
according to the American-European Consensus Group crite-
ria, and RA activity was evaluated by the Lansbury index (LI).
Confocal microscopy was used to investigate corneal thick-
ness, the number of epithelial and stromal cells, and keratocyte
hyperreflectivity. In addition, the sub-basal plexus was assessed
for the number, tortuosity, and reflectivity of the nerve fibers
and the presence of beadlike formations.
RESULTS. Sixteen percent of patients with RA also had SSII.
Between the SSII and non-SSII groups, no significant differ-
ences were found in the LI or in the clinical and confocal
variables. Significant differences were present between pa-
tients with RA and control subjects for all the variables studied
except nerve reflectivity. In patients with RA with and without
SSII, LI correlated significantly with the number of beadlike
formations and the number of hyperreflective, activated ker-
atocytes.
CONCLUSIONS. Confocal microscopy of patients with RA showed
several changes in corneal cells and nerves. The number of
beadlike formations and the number of activated keratocytes
could be interpreted as confocal signs of ocular surface disease
activity. These correlations with the index of systemic disease
activity, LI, may provide insight regarding the pathogenic
mechanisms of dry eye in patients with RA. (Invest Ophthal-
mol Vis Sci. 2008;49:560–564) DOI:10.1167/iovs.07-0893
Rheumatoid Arthritis (RA) is a chronic inflammatory auto-immune disease of unknown origin. It manifests itself
through an erosive, symmetric synovitis and frequently has
multiregional, extra-articular manifestations. Its course is
chronic, recurring in most cases with quiescent phases alter-
nating with relapses.1,2 The eye, and the ocular surface in
particular, is one of the regions frequently affected by this
disease.3,4 The most frequent eye complication of RA, though
not the most severe one, is keratoconjunctivitis sicca (KCS).
With extended criteria for the diagnosis of dry eye,5 the prev-
alence in RA is approximately 90%.
Approximately 11% to 31% of persons with RA have sec-
ondary Sjo¨gren’s syndrome (SSII). One of the main clinical
signs of SSII, as well as of primary Sjo¨gren’s syndrome, is KCS.6
The dry eye associated with Sjo¨gren’s syndrome is viewed as a
prototype not only of the KCS associated with autoimmune
diseases, but also of the hyposecretory dry eye in general.7,8
In this study we used confocal microscopy to analyze the
corneal morphologic alterations in patients with RA, with or
without SSII. We evaluated potential correlations between oc-
ular surface manifestations of RA and the activity of systemic
RA. These correlations are particularly interesting, because
recent reports suggest that there are profound etiologic and
pathogenic differences between KCS in patients with RA with
SSII and patients with RA without SSII, though they lack man-
ifest differences in the clinical indicators.5,9 Confocal micros-
copy appears to be an essential instrument for exploring the
nature of corneal alterations in such patients, as it provides
quick, noninvasive, in vivo microstructural evaluations.
METHODS
Patients
Fifty patients with RA were consecutively recruited (46 women and 4
men; average age, 52  13.1 years) after referral to our center by
rheumatologists. In all patients, the possible presence of SSII was
investigated in accordance with the American-European Consensus
Group criteria.10 These criteria require the presence of ocular or oral
symptoms and the presence of at least two of the following three
variables: ocular signs, histopathology in minor salivary glands, and
objective evidence of salivary gland involvement. The Lansbury index
(LI)11,12 was calculated to rate the degree of systemic RA activity. The
control group (C) included 30 healthy people (24 women and 6 men;
average age of 50.4  21.2 years) attending our general clinic.
The following were considered exclusion criteria: the presence of
lymphomas, AIDS, sarcoidosis, or diabetes mellitus; dystrophies or
inflammations of the ocular surface; systemic treatments with drugs
with known corneal toxicity; local treatments with drugs against glau-
coma and steroidal or nonsteroidal anti-inflammatory drugs (NSAIDs);
the use of contact lenses; and previous ophthalmic surgery. We also
excluded from the study those patients for whom the rheumatologist
in charge of the case expressed a negative opinion on the execution of
the anamnestic, clinical, and laboratory evaluations necessary to quan-
tify the LI and the possible diagnosis of SSII.
All participants signed an informed consent. The study was con-
ducted in accordance with the guidelines of the Helsinki Declaration
and the Italian privacy law.
Clinical Evaluation
An accurate medical history was drawn up for each participant in the
study, and all patients completed a questionnaire for a standardized
evaluation of dry eye–related symptoms (Ocular Surface Disease Index;
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OSDI).13 All the subjects included in the study underwent a thorough
ophthalmic evaluation, including biomicroscopic examination of ocu-
lar adnexa and anterior segment, evaluation of the breakup time of the
tear film (BUT), tear secretion (Schirmer test with local anesthetic),
corneal apex sensitivity (Cochet-Bonnet nylon thread aesthesiometer),
and corneal surface staining with sodium fluorescein 1% collyrium,
scored according to the van Bijsterveld method.14 Both eyes were
examined in all subjects. For statistical analysis of clinical and confocal
data, the eye recording the highest score with the van Bijsterveld
fluorescein test was selected. In case of equal score for the two eyes,
the discriminant criteria considered were, by order of relevance, the
lower corneal sensitivity and the lower score on the Schirmer test.
Confocal Microscopy
Image Acquisition. The examination with the confocal micro-
scope (Confoscan 2.0; Nidek Technologies, Vigonza, Italy) was con-
ducted in an area of 440 330 m, approximately at the corneal apex,
according to an already published procedure.15
Image Analysis. The scanned confocal images were analyzed by
the same masked investigator (EV). According to a previously de-
scribed method,15 we quantified the corneal and stromal thicknesses,
the cell densities of the superficial and basal epithelium, and the cell
densities of the anterior and posterior stroma. We quantified the
number of the sub-basal plexus nerve fibers visible in one frame and
the tortuosity and reflectivity of those fibers.16 We also counted the
number of beadlike formations per 100 m of nerve fiber, as described
by Benitez del Castillo et al.7 Finally, we quantified the number of
activated keratocytes, defined as the highest number of hyperreflective
keratocytes visible in one frame of stroma. A second independent
investigator analyzed the images, quantifying the cell density in the
different layers, the number of activated keratocytes, and the number
of beadlike formations. These data were used to calculate the interob-
server variance.
Statistical Analysis
All data are expressed as the mean SD. The normal distribution of the
variables was verified through the Kolmogorov-Smirnov test. Compar-
isons among the mean scores were made through one-way ANOVA
with least-significant difference (LSD) post hoc test. The correlations
among variables were studied with Spearman’s index of linear corre-
lation. The minimum criterion for tests of significance was P  0.05.
The statistical analysis was conducted with commercial software (SPSS
for Windows, ver. 12.0; SPSS Sciences, Chicago, IL).
RESULTS
Clinical Data
Eight (16%) of the 50 patients with RA had SSII. For the clinical
data derived from the OSDI questionnaire, the scores for the
patients with RA with SSII and those without it were signifi-
cantly greater than the control subjects (P  0.001, Table 1).
For BUT, Schirmer test, and corneal sensitivity, the scores for
patients with RA with and without SSII were significantly less
than those of the control subjects (P  0.001). None of the
variables analyzed were significantly different between the two
RA groups.
Pachymetry and Cell Density Data
Each observation by confocal microscopy took 1.5 to 2.5 min-
utes, and none of the participants showed any relevant alter-
ation of the ocular surface as a result of the examination. Both
TABLE 2. Corneal and Stromal Thicknesses: Confocal Data
Corneal Thickness Stromal Thickness
RA with SS 514.75  17.14 467.87  17.57
RA without SS 521.02  21.45 475.90  19.82
Control 559.23  24.46 499.43  25.38
P  0.001*  0.001†
P is by ANOVA.
* RA with SS vs. C, RA without SS vs. C; P  0.001, LSD. RA with
SS vs. RA without SS; P  0.468, LSD.
† RA with SS vs. C, RA without SS vs. C; P  0.001, LSD. RA with
SS vs. RA without SS; P  0.345, LSD.
TABLE 3. Cell Densities and Number of Activated Keratocytes: Confocal Data
Superficial Epithelium Basal Epithelium Anterior Stroma Posterior Stroma Activated Keratocytes
RA with SS 993.11  104.82 5980.32  192.58 1226.50  69.78 835.50  64.67 7.02  3.27
RA without SS 1024.92  183.02 5820.69  221.40 1190.88  90.97 800.78  116.08 5.89  4.08
Control 1511.60  130.95 5602.23  234.89 970.33  104.47 702.23  79.22 0.45  0.66
P  0.001*  0.001†  0.001‡  0.001§  0.001
P is by ANOVA.
* RA with SS vs. C, RA without SS vs. C; P  0.001, LSD. RA with SS vs. RA without SS; P  0.610, LSD.
† RA with SS vs. C, RA without SS vs. C; P  0.001, LSD. RA with SS vs. RA without SS; P  0.068, LSD.
‡ RA with SS vs. C, RA without SS vs. C; P  0.001, LSD. RA with SS vs. RA without SS; P  0.332, LSD.
§ RA with SS vs. C, RA without SS vs. C; P  0.001, LSD. RA with SS vs. RA without SS; P  0.369, LSD.
 RA with SS vs. C, RA without SS vs. C; P  0.001, LSD. RA with SS vs. RA without SS; P  0.355, LSD.
TABLE 1. Clinical Data
Questionnaire BUT Schirmer I Sensitivity Fluo LI
RA with SS 2.39  0.53 3.60  1.68 4.25  2.41 4.93  0.25 2.43  0.90 39.99  12.95
RA without SS 2.29  0.81 3.70  1.90 4.71  3.23 5.03  0.52 2.10  1.24 34.45  15.64
Control 0.52  0.56 10.47  1.83 14.83  3.47 5.85  0.38 — —
P  0.001*  0.001†  0.001‡  0.001§ 0.479 0.352
P is by ANOVA.
* RA with SS vs. C, RA without SS vs. C; P  0.001, LSD. RA with SS vs. RA without SS; P  0.586, LSD.
† RA with SS vs. C, RA without SS vs. C; P  0.001, LSD. RA with SS vs. RA without SS; P  0.806, LSD.
‡ RA with SS vs. C, RA without SS vs. C; P  0.001, LSD. RA with SS vs. RA without SS; P  0.716, LSD.
§ RA with SS vs. C, RA without SS vs. C; P  0.001, LSD. RA with SS vs. RA without SS; P  0.584, LSD.
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the cornea and stroma were significantly thinner in patients
with RA than in healthy subjects (P  0.001, Table 2). How-
ever, there were no differences between the two RA groups.
The density of cells (per square millimeter) in the superficial
epithelium, basal epithelium, anterior stroma, and posterior
stroma of the RA groups with or without SSII were not signif-
icantly different from one another (Table 3). Likewise, the
number of hyperreflective activated keratocytes (Fig. 1) was
similar in both RA groups. In comparison to control subjects,
the cell density of the superficial epithelium in both RA groups
was significantly lower (P  0.001). In contrast, the cell den-
sities of the basal epithelium, anterior stroma, and posterior
were all significantly greater than those of the control group
(P  0.001). Similarly, the number of activated keratocytes in
the both RA groups was greater than in the control subjects
(P  0.001). The interobserver variance was 3%, 2%, 5%, and
5% for the cell densities of the superficial epithelium, the basal
epithelium, the anterior stroma, and the posterior stroma,
respectively. It was 22% for the number of activated kerato-
cytes. There was strong correlation between the values ob-
tained by the two investigators for all variables (P  0.001;
Spearman).
Sub-basal Plexus Data
Within the sub-basal nerve plexus, the number of nerve fibers,
tortuosity, reflectivity, and beadlike formations were similar
among both RA groups (Table 4). However, the number of
nerves in the RA groups was significantly less than in the
control group, whereas the tortuosity and number of beadlike
formations (Fig. 2) was significantly greater (P  0.001). The
reflectivity was similar between the RA and control groups. For
beadlike formations, the interobserver variance was 8%, with a
strong correlation between the values obtained by the two
investigators (P  0.001, Spearman).
Correlations of Clinical and Confocal Data
There was a statistically significant correlation between the LI
and the Schirmer test for all patients with RA (P  0.05,
Spearman). This correlation was evident for the RA with SSII
group (P  0.05); however, it was not significant for the RA
without SSII group (P 0.065). The LI also correlated with the
number of beadlike formations and the number of activated
keratocytes in the RA group with SSII (P  0.01 and P  0.05
respectively; Figs. 3A, 3B). Similar correlations were also
present in the RA group without SSII (P  0.05 and P  0.05
respectively; Figs. 3C, 3D).
The patients with RA, both with and without SSII, showed
several significant correlations among the clinical and confocal
variables. The main ones are reported in Table 5.
DISCUSSION
In the past few years, confocal microscopy has offered new
opportunities to study the in vivo structure of the cornea. The
technique permits visualization of disease-related microstruc-
tural alterations in the cornea by means of a noninvasive
examination that is quick to execute and repeatable. According
to the model used in recent studies, we used confocal micros-
copy in a quantitative way to evaluate RA-related changes in
the cornea. In our opinion, this approach represents an impor-
tant evolution in the use and application of this technology.
As in a previous study of patients with Sjo¨gren’s syn-
drome,15 we found a surprising association between the stan-
dardized OSDI evaluation of symptoms and some clinical signs
of the ocular surface. Many articles in literature emphasize the
scant association between signs and symptoms in dry eye,17–19
whereas others report occasional associations8,20 or inverse
correlations.21 Such heterogeneous data are probably due to
the small size of the samples used in many of those studies and
to the characteristics of the different questionnaires used.
Both groups of our patients with RA had central corneal and
stromal thicknesses that were significantly thinner than the
control group. These changes also occur for KCS in general22
and for KCS combined with autoimmune disease.15,23 The
thinning could occur by increased apoptotic and proteolytic
phenomena of the stroma. Thinning may also be the result of
increased tangential forces that act on the epithelial surface
which can be abnormally irregular.
The superficial and basal epithelial cell densities and the
apparent24 anterior and posterior stromal cell densities in pa-
FIGURE 1. The activated keratocytes shown are hyperreflective stro-
mal cells.
TABLE 4. Number and Morphology of Subbasal Nerves: Confocal Data
Nerve Number Tortuosity Reflectivity Beadlike Formations
RA with SS 3.18  0.74 2.65  0.47 1.99  0.70 332.94  64.20
RA without SS 3.32  1.14 2.53  0.93 2.15  1.38 307.26  78.81
Control 4.99  0.81 1.33  0.60 2.02  1.01 196.16  0.66
P 0.001* 0.001† 0.874 0.001‡
P is by ANOVA.
* RA with SS vs. C, RA without SS vs. C; P  0.001, LSD. RA with SS vs. RA without SS; P  0.708,
LSD.
† RA with SS vs. C, RA without SS vs. C; P  0.001, LSD. RA with SS vs. RA without SS; P  0.699,
LSD.
‡ RA with SS vs. C, RA without SS vs. C; P  0.001, LSD. RA with SS vs. RA without SS; P  0.373,
LSD.
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tients with RA with SSII are similar to those previously re-
ported.15 We also found similar values in patients with RA
without SSII.
For patients in both RA groups, we observed a significantly
higher number of hyperreflective stromal cells than in the
control group. These keratocytes are in a specific stage of
metabolic activation induced by proinflammatory cytokines,
such as IL-1 and IL-6. Benitez del Castillo et al.8 have recently
discussed the key role played by those keratocytes in the
inflammatory process that is linked to dry eye–related disease.
As a matter of fact, the activated keratocytes are seemingly able
to produce nerve growth factor, thus making a relevant con-
tribution to the processes of activation and reorganization of
the nerve fibers of the sub-basal plexus. In both groups of
patients with RA, the nerve fibers showed increased tortuosity
and a higher number of beadlike formations, which could be
signs of metabolic activation of the plexus.25 This is consistent
with the correlations registered between the LI, an index of
activity of the systemic disease, and the number of activated
keratocytes and the number of beadlike formations in all pa-
FIGURE 2. Sub-basal nerve fibers
(A), with evident beadlike forma-
tions (B, arrows).
FIGURE 3. Correlations with the LI.
The LI index in the patients with RA
with SSII correlated significantly
with (A) the number of beadlike for-
mations (r  0.881; P  0.01) and
(B) the number of activated kerato-
cytes (r  0.714; P  0.01). In pa-
tients with RA without SSII, similar
correlations were evident for LI and
(C) the number of beadlike forma-
tions (r  0.383; P  0.05) and (D)
activated keratocytes (r 0.342; P
0.05).
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tients with RA. In a recent study, Fujita et al.5 explored the
possible correlations between RA activity and the alterations of
the ocular surface. They reported a significant association be-
tween clinical tests for the ocular surface and the systemic
disease only in patients who have RA with SSII. The validity and
repeatability of the correlations between the systemic disease
activity and the number of activated keratocytes and of bead-
like formations should be carefully verified in broader studies,
possibly conducted in a prospective way. Therefore, they can-
not be used at the moment to draw conclusions on the patho-
genic processes.
There were no differences in any of the variables that we
evaluated when patients with RA with SSII were compared
with patients with RA without SSII. These results are similar to
previous findings obtained comparing patient groups with pri-
mary and secondary Sjo¨gren’s syndrome15 and suggest that the
same kinds of inflammatory and neurodegenerative and regen-
erative changes occur in the different autoimmune types of dry
eye. These alterations show various intensities and associations
with the severity of both the ocular surface and the systemic
disease that are worthy of further studies.
In conclusion, confocal microscopy enabled us to identify
several alterations of cell activity and innervation of the cornea
in patients with RA with and without SSII. The potential of
confocal microscopy has not yet been fully investigated for the
study of pathologic processes and the complex interaction
between the ocular surface and autoimmune systemic diseases.
Our results are a stimulus for further development of new
approaches to confocal microscopy in patients with KCS and
autoimmune diseases. This approach may lend itself to the
identification of some indexes of disease activity on the ocular
surface that could be compared with the indexes of activity of
the systemic disease.
References
1. Grassi W, De Angelis R, Lamanna G, Cervini C. The clinical features
of rheumatoid arthritis. Eur J Radiol. 1998;27(suppl 1):S18–S24.
2. Scutellari PN, Orzincolo C. Rheumatoid arthritis: sequences. Eur J
Radiol. 1998;27(suppl 1):S31–S38.
3. Robin J, Dugel R. Immunologic Disorders of the Cornea and
Conjunctiva. New York: Churchill Livingstone; 1988:533–537.
4. Jabs D. Ocular Manifestations of the Rheumatic Diseases.
Philadelphia: JB Lippincott; 1992;1–5.
5. Fujita M, Igarashi T, Kurai T, et al. Correlation between dry eye and
rheumatoid arthritis activity. Am J Ophthalmol. 2005;140:808–
813.
6. Fox RI, Stern M, Michelson P. Update in Sjogren syndrome. Curr
Opin Rheum. 2000;12:391–398.
7. Benitez del Castillo JM, Wasfy MA, Fernandez C, Garcia-Sanchez J.
An in vivo confocal masked study on corneal epithelium and
sub-basal nerves in patients with dry eye. Invest Ophthalmol Vis
Sci. 2004;45:3030–3035.
8. Benitez del Castillo JM, Acosta MC, Wassfi MA, et al. Relation
between corneal innervation with confocal microscopy and cor-
neal sensitivity with noncontact esthesiometry in patients with dry
eye. Invest Ophthalmol Vis Sci. 2007;48:173–181.
9. Lemp MA. Dry eye (keratoconjunctivitis sicca), rheumatoid arthri-
tis, and Sjogren’s syndrome. Am J Ophthalmol. 2005;140:898–
899.
10. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for
Sjo¨gren’s syndrome: a revised version of the European criteria
proposed by the American-European Consensus Group. Ann
Rheum Dis. 2002;61:554–558.
11. Lansbury J. Quantitation of the activity of rheumatoid arthritis, I: a
method for recording its systemic manifestations. Am J Med Sci.
1956;231:616–621.
12. Lansbury J. Numerical method of evaluating the status of rheuma-
toid arthritis. Ann Rheum Dis. 1958;17:101–107.
13. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL.
Reliability and validity of the Ocular Surface Disease Index. Arch
Ophthalmol. 2000;118:615–621.
14. van Bijsterveld OP. Diagnostic tests in the sicca syndrome. Arch
Ophthalmol. 1969;82:10–14.
15. Villani E, Galimberti D, Viola F, Mapelli C, Ratiglia R. The cornea in
Sjo¨gren’s syndrome: an in vivo confocal study. Invest Ophthalmol
Vis Sci. 2007;48:2017–2022.
16. Oliveira-Soto L, Efron N. Morphology of corneal nerves using
confocal microscopy. Cornea. 2001;20:374–384.
17. Schein OD, Tielsch JM, Munoz B, Bandeen-Roche K, West S.
Relation between signs and symptoms of dry eye in the elderly: a
population-based perspective. Ophthalmology. 1997;104:1395–
1401.
18. Hay EM, Thomas E, Pal B, Hajeer A, Chambers H, Silman AJ. Weak
association between subjective symptoms or and objective testing
for dry eyes and dry mouth: results from a population based study.
Ann Rheum Dis. 1998;57:20–24.
19. Nichols KK, Nichols JJ, Mitchell GL. The lack of association be-
tween sign and symptoms in patients with dry eye disease. Cor-
nea. 2004;23:762–770.
20. Bjerrum KB. Test and symptoms in keratoconjunctivitis sicca and
their correlation. Acta Ophthalmol Scand. 1996;74:436–441.
21. Adatia FA, Michaeli-Cohen A, Naor J, Caffery B, Bookman A, Slo-
movic A. Correlation between corneal sensitivity, subjective dry
eye symptoms and corneal staining in Sjo¨gren’s syndrome. Can J
Ophthalmol. 2004;39:767–771.
22. Liu Z, Pflugfelder SC. Corneal thickness is reduced in dry eye.
Cornea. 1999;18:403–407.
23. Tuominen IS, Konttinen YT, Vesaluoma MH, Moilanen JA, Helinto
M, Tervo TM. Corneal innervation and morphology in primary
Sjo¨gren’s syndrome. Invest Ophthalmol Vis Sci. 2003;44:2545–
2549.
24. Patel SV, McLaren JW, Hodge DO, Bourne WM. Normal human
keratocyte density and corneal thickness measurement by using
confocal microscopy in vivo. Invest Ophthalmol Vis Sci. 2001;42:
333–339.
25. Zhang M, Chen J, Luo L, Xiao Q, Sun M, Liu Z. Altered corneal
nerves in aqueous tear deficiency viewed by in vivo confocal
microscopy. Cornea. 2005;24:818–824.











Superficial epithelium 0.01 0.001
Basal epithelium 0.01 0.001
Tortuosity 0.01 0.01
Number of nerves 0.01 0.01
Fluo
Superficial epithelium 0.01 0.001
Basal epithelium 0.01 0.001
Tortuosity 0.01 0.01
Number of nerves 0.01 0.05
Sensitivity
Tortuosity 0.05 0.001
Number of nerves 0.01 0.074
P is by Spearman linear correlation index.
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